JP
JCR Pharmaceuticals
Japanese biopharmaceutical company developing biologics and gene therapies for CNS and rare diseases.
Rate
About
JCR Pharmaceuticals Co., Ltd. is a publicly listed Japanese biopharmaceutical company founded in 1975, headquartered in Ashiya, Hyogo. It develops and commercializes biologics and gene therapies for central nervous system and rare diseases, including enzyme replacement therapies and proprietary JUST-AAV gene therapy capsids licensed to partners including Alexion.
Technology stack
detected 2026-06-20Est. monthly stack spend~$420/mo
Emailnone
Hosting
self_managed
Stack
jQuery
Bootstrap
WordPress
Analytics
Google Tag Manager
SEO
Yoast SEO
Compliance
GDPR
Cookie consent
OneTrust
Comments
No comments yet. Be the first to share your take.
Frequently asked
What does JCR Pharmaceuticals do?
JCR Pharmaceuticals Co., Ltd. is a publicly listed Japanese biopharmaceutical company founded in 1975, headquartered in Ashiya, Hyogo. It develops and commercializes biologics and gene therapies for central nervous system and rare diseases, including enzyme replacement therapies and proprietary JUST-AAV gene therapy capsids licensed to partners including Alexion.
Where is JCR Pharmaceuticals headquartered?
JCR Pharmaceuticals is headquartered in Ashiya, Japan.
When was JCR Pharmaceuticals founded?
JCR Pharmaceuticals was founded in 1975.
What industry does JCR Pharmaceuticals operate in?
JCR Pharmaceuticals operates in Biotech, Pharmaceuticals, Gene Therapy.